BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 20012434)

  • 1. The clinicopathological analysis of 303 cases with malignant lymphoma classified according to the World Health Organization classification system in a single institute of Taiwan.
    Chen WL; Tsai WC; Chao TY; Sheu LF; Chou JM; Kao WY; Chen YC; Ho CL
    Ann Hematol; 2010 Jun; 89(6):553-62. PubMed ID: 20012434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical (IHC) Analysis of Non-Hodgkin's Lymphoma (NHL) Spectrum According to WHO/REAL Classification: A Single Centre Experience from Punjab, India.
    Sharma M; Mannan R; Madhukar M; Navani S; Manjari M; Bhasin TS; Gill KS
    J Clin Diagn Res; 2014 Jan; 8(1):46-9. PubMed ID: 24596721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency and diagnostic patterns of lymphomas in liver biopsies with respect to the WHO classification.
    Loddenkemper C; Longerich T; Hummel M; Ernestus K; Anagnostopoulos I; Dienes HP; Schirmacher P; Stein H
    Virchows Arch; 2007 May; 450(5):493-502. PubMed ID: 17431676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multifocal Primary Extranodal Non-Hodgkin Lymphoma: A Report of a Rare Case.
    Kani V; Ravichandran A; Grace Priyadarshini S; Diwagar N; Esakki M
    Cureus; 2024 Mar; 16(3):e57105. PubMed ID: 38681473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New classifications of malignant lymphomas - What changes are relevant for practice?].
    Hartmann S; Rudelius M
    Dtsch Med Wochenschr; 2024 May; 149(11):613-620. PubMed ID: 38749437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphoma incidence, survival and prevalence 2004-2014: sub-type analyses from the UK's Haematological Malignancy Research Network.
    Smith A; Crouch S; Lax S; Li J; Painter D; Howell D; Patmore R; Jack A; Roman E
    Br J Cancer; 2015 Apr; 112(9):1575-84. PubMed ID: 25867256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epiregulin: A new prognostic molecule in non-Hodgkin lymphoma.
    Demir I; Akan OY; Bilgir F; Yilmaz I; Bozkaya G; Bilgir O
    Ir J Med Sci; 2024 Jan; ():. PubMed ID: 38270775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral manifestations of lymphoma: a systematic review.
    Silva TD; Ferreira CB; Leite GB; de Menezes Pontes JR; Antunes HS
    Ecancermedicalscience; 2016; 10():665. PubMed ID: 27594910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LBD: a manually curated database of experimentally validated lymphoma biomarkers.
    Tan B; Xin S; Hu Y; Feng C; Chen M
    Database (Oxford); 2022 Jul; 2022():. PubMed ID: 35788654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary Adrenal Lymphoma: Two Case Series From China.
    Zeng J; Yan F; Chen Y; Zang L; Chen K; Lyu Z; Dou J; Mu Y; Lin M; Yang G
    Front Endocrinol (Lausanne); 2021; 12():778984. PubMed ID: 35154000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological study and outcomes of primary extranodal lymphoma.
    Nanthakwang N; Rattarittamrong E; Rattanathammethee T; Chai-Adisaksopha C; Tantiworawit A; Norrasethada L; Ya-In C
    Hematol Rep; 2019 Nov; 11(4):8227. PubMed ID: 31871611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential development of multifocal recurrent non-Hodgkin's lymphoma of mucosa-associated lymphoid tissue and diffuse large B-Cell lymphoma in a single patient: A case report.
    Yang X; Min X; He W
    Medicine (Baltimore); 2018 May; 97(21):e10845. PubMed ID: 29794780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Previous Exposure to Statin May Reduce the Risk of Subsequent Non-Hodgkin Lymphoma: A Nationwide Population-Based Case-Control Study.
    Cho SF; Yang YH; Liu YC; Hsiao HH; Huang CT; Wu CH; Tsai YF; Wang HC; Liu TC
    PLoS One; 2015; 10(10):e0139289. PubMed ID: 26425850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell lymphoma with von Hippel-Lindau disease: a rare case report and review of literature.
    Lou LH; Shen H; Lin J; Yan YW; Peng Y; Lu JH; Xu Q; Jiang HQ
    Int J Clin Exp Pathol; 2015; 8(5):5837-43. PubMed ID: 26191306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of second primary malignancy in patients with non-Hodgkin lymphoma: a nationwide population-based study.
    Chien SH; Liu CJ; Hong YC; Teng CJ; Hu YW; Ku FC; Yeh CM; Chiou TJ; Gau JP; Tzeng CH
    J Cancer Res Clin Oncol; 2015 Nov; 141(11):1995-2004. PubMed ID: 25971624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical analysis of 1629 newly diagnosed malignant lymphomas in current residents of Sichuan province, China.
    Wang XM; Bassig BA; Wen JJ; Li GD; Liu ZB; Yao WX; Hu W; Wang Y; Li JM; Wang XD; Gan MZ; Wang CS; Xu G; Rothman N; Lan Q; Xu CG
    Hematol Oncol; 2016 Dec; 34(4):193-199. PubMed ID: 25824105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral T and NK cell non-hodgkin lymphoma a challenge for diagnosis.
    Vasile D; Vladareanu AM; Bumbea H
    Maedica (Bucur); 2014 Mar; 9(1):104-8. PubMed ID: 25553137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant lymphoma in Eastern India: A retrospective analysis of 455 cases according to World Health Organization classification.
    Mondal SK; Mandal PK; Samanta TK; Chakaborty S; Roy SD; Roy S
    Indian J Med Paediatr Oncol; 2013 Oct; 34(4):242-6. PubMed ID: 24604951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphotoxin alpha (LTA) polymorphism is associated with prognosis of non-Hodgkin's lymphoma in a Chinese population.
    Zhang Y; Chen MB; Zhou XY; Hong XN
    PLoS One; 2013; 8(6):e66411. PubMed ID: 23840460
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.